Trials / Unknown
UnknownNCT04885946
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Christian Hvas · Academic / Other
- Sex
- All
- Age
- 18 Years – 130 Years
- Healthy volunteers
- Not accepted
Summary
Clostridioides difficile (CD) infection (CDI) is a global health threat with an urgent need for new treatment strategies. Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (CDI), and is currently recommended for multiple (three or more), recurrent CDI infections. The role of FMT earlier in the treatment hierarchy of CDI remains to be determined. In this randomized, double-blinded, placebo-controlled clinical trial, we compare FMT with placebo following standard antibiotic treatment for first or second Clostridioides difficile infection.
Detailed description
This is a parallel arm placebo-controlled clinical trial. We aim to include 84 adult patients with their first or second episode of Clostridioides difficile (formerly Clostridium difficile) infection. All patients receive vancomycin standard therapy. Patients are randomised in a 1:1 ratio to two treatments with capsules that contain either FMT+FMT or placebo+placebo. The primary outcome is absence of C difficile-associated disease 8 weeks after randomisation. Patients who have fulminant disease where it is deemed unethical to give placebo are offered open-label FMT. The primary outcome in patients with fulminant C difficile infection is 8 weeks mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal microbiota transplantion (FMT) | Single donor, fecal microbiota transplantion (FMT) from healthy human donors. |
| OTHER | Placebo | Food coloring, water, glycerol |
Timeline
- Start date
- 2021-06-02
- Primary completion
- 2022-03-31
- Completion
- 2024-12-31
- First posted
- 2021-05-13
- Last updated
- 2022-06-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04885946. Inclusion in this directory is not an endorsement.